Tb-based radioimmunotherapy has a strong potential to eliminate ovarian cancer stem cells, providing a precise and lasting ...

Tumor markers are substances that can often be detected in higher-than-normal amounts in the blood, urine, or body tissues of some patients with certain types of cancer. Tumor markers are ...

Video content above is prompted by the following: Impact of Tumor Heterogeneity on Testing Reliability Although ovarian cancer shows relatively limited spatial and temporal heterogeneity compared ...

In a twist no one expected, researchers found that many HV tumors express CA125, a marker known for its role in ovarian cancer. This means that 1 in 4 bladder cancer cases may be hiding this ...

From these, the researchers were able to analyze mRNA sequence data from 296 ovarian cancers and 1,839 normal tissue samples. Using this bioinformatics approach, the researchers identified six mRNA ...

You can take Lynparza for HRD-positive ovarian cancer that is advanced (it has spread beyond the initial tumor but has not spread to other parts of the body) and that has been treated with ...

How ovarian cancer disables immune cells Date: October 23, 2024 Source: Weill Cornell Medicine Summary: Researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and ...

They targeted tumor protein p53 (TP53), a gene which is mutated and nonfunctional in over 96% of aggressive ovarian cancer cases. This mutated gene is common in other human cancers and animal ...